Abstract
Estimated all-cause mortality within 30-days of hypoglycemic emergencies is 0.8 %
in adults with type 1 diabetes and 1.7 % with type 2 diabetes; and within 30-days
of hyperglycemic emergencies, it is 1.2 % with type 1 diabetes and 2.8 % with type
2 diabetes. These rates changed little between 2011 and 2020.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Diabetes Research and Clinical PracticeAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type 2 diabetes.Endocr Pract. 2013; 1–28
- Increased mortality of patients with diabetes reporting severe hypoglycemia.Diabetes Care. 2012; 35: 1897-1901
- Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients.BMJ. 2019; 365l1114
- Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study.Endocrine. 2016; 51: 72-82
- Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.Diabetes Care. 2015; 38: 316-322
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.BMJ. 2010; 340b4909
- Optum labs: building a novel node in the learning health care system.Health Aff (Millwood). 2014; 33: 1187-1194
- National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) Comprehensive Diabetes Care.National Committee for Quality Assurance, Washington, DC2015: 74-98
- Association of Cumulative multimorbidity, glycemic control, and medication use with hypoglycemia-related emergency department visits and hospitalizations among adults with diabetes.JAMA Netw Open. 2020; 3e1919099
- Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020.JAMA Netw Open. 2021; 4: e2123471
- Hospitalizations for chronic disease and acute conditions in the time of COVID-19.JAMA Intern Med. 2021; 181: 269-271
- Rates of hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011–2020.Diabetes Care. 2023; 46: e69-e71
- Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE).J Gen Intern Med. 2010; 25: 962-968
- HbA1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging study.Diabetes Care. 2013; 36: 3535-3542
- Surveillance of hypoglycemia—limitations of emergency department and hospital utilization data.JAMA Intern Med. 2018; 178: 987-988
- Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry.Diabetes Care. 2015; 38: 971-978
- Glucagon use by U.S. adults with type 1 and type 2 diabetes.J Diabetes Complications. 2021; 35107882
- Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.BMJ Open Diabetes Res Care. 2020; 8e001007
Article info
Publication history
Published online: January 21, 2023
Accepted:
January 19,
2023
Received in revised form:
January 12,
2023
Received:
December 12,
2022
Identification
Copyright
© 2023 Elsevier B.V. All rights reserved.
